13C MOLECULAR, INC.

ACM Global Laboratories, an affiliate of Rochester Regional Health in Rochester, New York, is a recognized leader in medical diagnostic and global clinical trial testing services. ACM Global Laboratories operates in more than 65 countries around the globe, with wholly owned facilities in the U.S.A., England, China, India, and Singapore. Our full-time staff of laboratory experts performs more than 20 million tests annually, spanning all medical disciplines including pathology, microbiology, molecular diagnostics, toxicology and more.

For more information, visit www.ACMGlobalLab.com or call 1-866-405 0400

Ares Genetics - a Vienna based startup - is revolutionizing how we address the global challenge of antimicrobial resistance (AMR).

To enable better infection control and more targeted patient care, Ares Genetics aims to provide unprecedented insight into AMR through next generation sequencing (NGS) and artificial intelligence (AI) powered solutions.
Innovative machine learning driven bioinformatics and the extensively curated ARESdb database comprehensively detect and interpret the genetic profile of pathogens.
Unlike conventional molecular assays, Ares Genetics solutions not only detect AMR markers but shed light on prevalence and diagnostic performance for these markers and predict how pathogens will respond to therapy.

Imprint: https://www.ares-genetics.com/imprint

Are you a researcher looking for guidance using human or veterinary samples & data? Or a biobanker looking for services to improve and promote your collections?

BBMRI-ERIC is a European Research Infrastructure for biobanking and biomolecular resources, providing services to the biobanking community in the following areas:
-Ethical, Legal and Societal Issues (ELSI)
-Quality Management
-IT (including the BBMRI-ERIC Directory of samples & data and Negotiator tool)

is a research infrastructure for biobanks and biomolecular resources, co-Co-funded by the European Commission within the Research Infrastructures programme of Horizon 2020, we have 20 member states and 1 international organization, making us one of the largest research infrastructures in the biomedical sciences. Our vision is to further build and strengthen value-added sustainable biobanking for all stakeholders, enabling academia and industry to make new treatments possible. To that end we offer services in Quality Management, ELSI (ethical, legal and societal issues) and IT, including the world’s largest directory of over 100 million samples and datasets from more than 600 biobanks across Europe.

Members: Austria, Belgium, Bulgaria, Czech Republic, Estonia, Finland, Germany, Greece, Italy, Malta, Latvia, the Netherlands, Norway, Poland, Sweden, UK

Observers: Cyprus, Lithuania, Switzerland, Turkey, IARC/WHO

Legal notice: http://www.bbmri-eric.eu/legalnotice/

Modern scientists are faced with a multitude of tasks, but many are not adequately supported in-house to perform all of them well.

To finance their research programmes researchers rely more and more on a mix of externally raised funds. But competition is increasing due to stagnating national research funds, which makes scientists look for alternatives on the international scene. Therefore, many internationally visible researchers in the life sciences turn to professional support to ensure their research proposals are competitive.

Proposals:
biolution has more than 12 years of experience in supporting life scientists successfully in the application for national and EU funds for research projects. Based on successful performance during FP7, biolution has become Austria’s premier service provider to apply for funding within the frame work programme or nationally.

Images:
biolution has assembled a visualisation pipeline based on the multidisciplinary expertise of its team and more than a decade of experience in explaining research. The inspiration was to generate affordable animations, which are rooted in scientific accuracy and extend into inspiring dynamic visualisations. It is our ambition to support researchers in their communication tasks with a dynamic representation of their favourite molecule or molecular process.
For our images follow us on Instagram: https://www.instagram.com/biolution_net/?hl=en

EPHORAN Multi-Imaging Solutions is a Contract Research Organization providing imaging expertise and knowledge to study, develop and promote the application of imaging technologies in preclinical drug research and development.

EPHORAN provides the opportunity to apply a translational pharmacological approach in drug R&D, evaluating in animal models a molecular-based proof of biological activity and mechanism of action, and translating it into the clinical setting. All the Techniques extensively employed in the clinical setting(e.g. PET, CT, SPECT, MRI, US and in Optical Imaging, both visible light and Near Infra Red) are available.

EPHORAN fosters the development of diagnostic tools, reagents and methodologies for experimental imaging and makes the drug development faster and more cost effective. Pharmaceutical companies will take advantage from its preclinical imaging technologies to carry on more effectively their R&D projects in different therapeutic such as oncology, cardiovascular and CNS. The application of Imaging techniques allows a significant reduction of the time-to-market of novel compounds. Other users that will benefit from access to Ephoran’s services are Researchers from academic and research institution.